Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corbo, M.
Right arrow Articles by Hays, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corbo, M.
Right arrow Articles by Hays, A. P.
NEUROLOGY 1993;43:809
© 1993 American Academy of Neurology

Localization of GM1 and Gal(ß1-3)GalNAc antigenic determinants in peripheral nerve

Massimo Corbo, MD, Angelo Quattrini, MD, Norman Latov, MD, PhD and Arthur P. Hays, MD

Departments of Pathology (Division of Neuropathology) (Drs. Corbo, Quattrini, and Hays) and Neurology (Drs. Corbo, Quattrini, and Latov), Columbia Presbyterian Medical Center, College of Physicians and Surgeons of Columbia University, New York, NY. Drs. M. Corbo and A. Quattrini are from the Department of Neurology of the I.R.C.C.S. S. Raffaele, University of Milan, Italy.

Anti-GM1 antibodies in patients with motor neuropathy or motor neuron disease frequently recognize the Gal(ß1-3)GalNAc epitope, which is shared by several glycoproteins in peripheral nerve. In this study, cholera toxin (CT), which is specific for GM1, and the lectin peanut agglutinin (PNA), which binds to Gal(ß1-3)GalNAc-bearing glycoproteins, were used in tissue section and intraneural injection studies to examine the distribution of GM1 and Gal(ß1-3)GalNAc epitopes in human and rat peripheral nerve by epifluorescence and confocal microscopy. In tissue sections, CT stained the compact myelin in both human and rat nerves, whereas PNA was localized at the outer edge of the myelin sheath or Schwann cell membrane. Following intraneural injection into rat sciatic nerves, both CT and PNA bound to the nodes of Ranvier, although CT was concentrated in the paranodal myelin region whereas PNA was concentrated at the nodal gap. These structures may be targets for anti-GMl antibodies in peripheral nerve.

Address correspondence and reprint requests to Dr. Norman Latov, Department of Neurology, Columbia University, Black Bldg 3-323, 650 W. 168th Street, New York, NY 10032.

Supported by a Center Grant from the NIH (NINCDS NS11766) to Columbia University, a grant from the Muscular Dystrophy Association to N.L., and National Science Foundation grants DMB-8515392 and DIR-8908095 to Dr. P.R. Smith at New York University (The authors used Dr. Smith's facility, which was funded.). Dr. Corbo is the recipient of a Research Fellowship from the Muscular Dystrophy Association. Dr. A. Quattrini is the recipient of a Postdoctoral Fellowship from the I.R.C.C.S. S. Raffaele, Milan, Italy.

Received June 18,1992. Accepted for publication in final form August 21,1992.




This article has been cited by other articles:


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
E. Hatzifilippou, E. Koutsouraki, T. Banaki, M. Traka, V. G. Costa, and S. J. Baloyannis
Antibodies Against GM1 in Demented Patients
American Journal of Alzheimer's Disease and Other Dementias, June 1, 2008; 23(3): 274 - 279.
[Abstract] [PDF]


Home page
BrainHome page
H. J. Willison and N. Yuki
Peripheral neuropathies and anti-glycolipid antibodies
Brain, December 1, 2002; 125(12): 2591 - 2625.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
Y. Gong, Y. Tagawa, M. P. T. Lunn, W. Laroy, M. Heffer-Lauc, C. Y. Li, J. W. Griffin, R. L. Schnaar, and K. A. Sheikh
Localization of major gangliosides in the PNS: implications for immune neuropathies
Brain, November 1, 2002; 125(11): 2491 - 2506.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
M. M. Prendergast and A. P. Moran
Review: Lipopolysaccharides in the development of the Guillain-Barre syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies
Innate Immunity, October 1, 2000; 6(5): 341 - 359.
[Abstract] [PDF]


Home page
NeurologyHome page
B. Buchwald, J. Bufler, M. Carpo, F. Heidenreich, R. Pitz, J. Dudel, E. Nobile-Orazio, and K.V. Toyka
Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome
Neurology, January 9, 2000; 56(1): 67 - 74.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. A. Sheikh, T. J. Deerinck, M. H. Ellisman, and J. W. Griffin
The distribution of ganglioside-like moieties in peripheral nerves
Brain, March 1, 1999; 122(3): 449 - 460.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
I. Nachamkin, B. M. Allos, and T. Ho
Campylobacter Species and Guillain-Barre Syndrome
Clin. Microbiol. Rev., July 1, 1998; 11(3): 555 - 567.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
R. H. Quarles
The Spectrum and Pathogenesis of Antibody-mediated Neuropathies
Neuroscientist, May 1, 1997; 3(3): 195 - 204.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by AAN Enterprises, Inc.